AOL

FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients

On Monday, the FDA approved Medtronic plc’s (NYSE:MDT) BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI) for patients with Parkinson’s disease. Deep brain ...
Nasdaq

Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever There is no cure for debilitating ...
Morning Overview on MSN

Deep brain stimulation is being tested as an option for treatment-resistant depression

A multi-center clinical trial is now enrolling patients to test whether surgically implanted electrodes delivering continuous ...

Nexalin Announces Peer-Reviewed Study Showing the Company’s DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents

BMC Psychiatry publication reports statistically significant reductions in self-injury behaviors and depressive symptoms, with brain-network ...
Healio

FDA approves first adaptive deep brain stimulation system for Parkinson’s disease

Please provide your email address to receive an email when new articles are posted on . The adaptive deep brain stimulation technology is the first of its kind to address symptoms of Parkinson’s ...
MedPage Today

FDA Approves Adaptive Deep Brain Stimulator for Parkinson's Disease

The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode identifier) for people with Parkinson's disease, Medtronic announced Monday. Like ...